These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38125110)

  • 1. Retracted: Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9790580. PubMed ID: 38125110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer.
    Song X; Wang P; Feng R; Chetry M; Li E; Wu X; Liu Z; Liao S; Lin J
    Evid Based Complement Alternat Med; 2023; 2023():9349494. PubMed ID: 37101716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer.
    Oncology JO
    J Oncol; 2023; 2023():9807856. PubMed ID: 37946722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9787264. PubMed ID: 37810555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
    International BR
    Biomed Res Int; 2024; 2024():9789013. PubMed ID: 38550155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: EF-Hand Domain-Containing Protein D2 (EFHD2) Correlates with Immune Infiltration and Predicts the Prognosis of Patients: A Pan-Cancer Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9805423. PubMed ID: 38094371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9758202. PubMed ID: 37860319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Correlation Analysis of Ultrasound Elastography Score with Invasive Breast Cancer and Biological Prognostic Factors.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9871968. PubMed ID: 37520040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors.
    International SC
    Stem Cells Int; 2024; 2024():9898676. PubMed ID: 38298238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Prognostic Diagnosis for Breast Cancer Patients Using Probabilistic Bayesian Classification.
    International BR
    Biomed Res Int; 2024; 2024():9834396. PubMed ID: 38230042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9893576. PubMed ID: 37387801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: A Comprehensive Pan-Cancer Analysis of the Tumorigenic Effect of Leucine-Zipper-Like Transcription Regulator (LZTR1) in Human Cancer.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9863454. PubMed ID: 37565172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9870383. PubMed ID: 37621621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Identification of Novel CircRNA-miRNA-mRNA Regulatory Network and Its Prognostic Prediction in Breast Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9870845. PubMed ID: 37387864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9758427. PubMed ID: 37475952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9792854. PubMed ID: 37829426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted:
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9867274. PubMed ID: 38094437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Identification of Immune-Related Prognostic Markers in Gastric Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862096. PubMed ID: 37772021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.